Mayo Clinic Arizona and VCU Medical Center Honored for Bridging 100%
of CardioWest Artificial Heart Patients to Transplant in 2007
TUCSON, Ariz. (Business Wire EON) April 23, 2008 --
SynCardia Systems, Inc.,
manufacturer of the CardioWest™
temporary Total Artificial Heart (TAH-t), has honored Mayo Clinic
Arizona and Virginia Commonwealth University Medical Center as
CardioWest 100% Centers for 2007.
Both hospitals bridged 100% of their patients who received a CardioWest
artificial heart to a donor heart transplant in 2007. Dr. Vigneshwar
Kasirajan, Chair of Cardiothoracic Surgery for VCU Medical Center, has
reached this milestone two years in row. Since VCU Medical Center became
CardioWest certified on April 3, 2006, they have bridged eight of their
CardioWest patients to transplant – four in
2006 and four in 2007.
“SynCardia’s
CardioWest TAH-t is capable of supporting the sickest of patients with
outstanding survival,” said Dr. Kasirajan. “We
are honored to be a part of this award and a part of this CardioWest
program.”
Mayo Clinic Arizona became a CardioWest certified center on Aug. 22,
2007. Since then, Dr. Francisco Arabia, Heart Transplant Program
Surgical Director, and his team have bridged all five of their
CardioWest patients to transplant.
“Our success with this device is a tribute to
both our expert medical staff and the proven life-saving capabilities of
this device,” said Dr. Arabia. “With
the TAH-t, we can help some of the sickest patients get a second chance
at life.”
The CardioWest artificial heart is approved as a bridge-to-transplant
for patients dying from end stage biventricular failure. These patients
are often days, if not hours from death. Their survival depends on
receiving a donor heart, or a CardioWest artificial heart as a bridge to
human heart transplant.
There are currently 24
CardioWest certified centers worldwide, with nine additional
hospitals undergoing the certification process.
The CardioWest artificial heart is the first and only FDA, Health
Canada and CE Mark approved temporary Total Artificial Heart in the
world.
In the 10-year pivotal clinical study of the CardioWest artificial
heart (New
England Journal of Medicine 2004; 351: 859-867), 79 percent of
patients receiving the CardioWest survived to transplant. This is the
highest bridge-to-transplant rate for any heart device in the world.
There have been more than 715 implants of the CardioWest, accounting for
more than 125 patient years of life on the artificial heart.
MULTIMEDIA GALLERY http://www.businesswire.com/cgi-bin/mmg.cgi?eid=5665611
Post Comment:
Trackback URL: http://eon.businesswire.com/pingpr.php/Q291cC1Ib3JyLUhhbGYtVGhpci1GYWx1LVplcm8=
Bookmark -
Del.icio.us |
Digg |
Furl It |
Spurl |
RawSugar |
Simpy |
Shadows |
Blink It |
My Web
|
